InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Li Kei Ling, Executive. Insider active across 1 company, notably Dawnrays Pharmaceutical (Holdings) Ltd.. In total, 8 filings have been logged. History available since 30 March 2026. The latest transaction was filed on 25 June 2026 (Purchase). Regulator: HKEX. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Li Kei Ling is an executive at Dawnrays Pharmaceutical (Holdings) Ltd. She is involved in managing and strategizing for the company, which specializes in the pharmaceutical sector. Her role is essential for the development and innovation of the company.